期刊文献+

雷洛昔芬对去卵巢大鼠血压的影响

The effect of raloxifene on blood pressure in ovariectomized rats
在线阅读 下载PDF
导出
摘要 目的探讨雷洛昔芬对去卵巢大鼠血压的影响。方法40只12周龄雌性SD大鼠随机均分为5组:去卵巢组、假手术对照组、雌激素组(倍美力,1mg·kg-1·d-1)、小剂量雷洛昔芬组(易维特,1mg·kg-1·d-1)和大剂量雷洛昔芬组(易维特,3mg·kg-1·d-1),测量治疗前、后各组血压的变化。结果去卵巢组血清雌二醇水平显著低于假手术对照组,雌激素或雷洛昔芬治疗后雌二醇水平都上升(P<0.01)。卵巢切除前5组大鼠之间的收缩压差异无统计学意义,3个月后去卵巢组收缩压明显升高,高于治疗前及治疗后其他各组收缩压的水平。雌激素或雷洛昔芬治疗后,收缩压水平下降,低于去卵巢组[治疗后:去卵巢组(128.46±15.78)mmHg,假手术对照组(104.48±15.03)mmHg,雌激素组(106.83±13.52)mmHg,小剂量雷洛昔芬组(109.55±11.23)mmHg,大剂量雷洛昔芬组(107.57±17.56)mmHg,P<0.01]。结论雷洛昔芬可降低去卵巢大鼠收缩压水平,有助于降低绝经后的心血管危险。 Objective To investigate the effect of raloxifene on blood pressure in ovariectomized rats. Methods Forty twelve-week old female Sprague-Dawley rats were randomly divided into five groups:ovariectomy, sham operation, ovariectomy + estrogen( 1 mg·kg^-1·d^-1), ovariectomy + small dose raloxifene( 1 mg·kg^-1·d^-1), ovariectomy + large dose raloxifene (3 mg·kg^-1·d^-1 ). Serum estradiol and blood pressure were measured before and after three months treatment. Results Serum estradiol was significantly lower in ovariectomized rats than that in sham operated animals. Serum estradiol was increased after the treatment of raloxifene (P〈0.01).The systolic blood pressure (SBP) was significantly higher in ovariectomized rats than that of other groups, SBP was decreased after the treatment of raloxifene(P〈0.01 ). [ after treatment OVX : ( 128.46±15.78)mm Hg vs Control : ( 104.48±15.03 )mm Hg vs E (106.83±13.52)mm Hg vs Rs:(109.55±11.23)mm Hg vs R1:(107.57±17.56) mm Hg,P〈0.01). Conclusion Raloxifene could decreased the blood pressure of ovariectomized rats, and may be benefet in the prevention of cardiovascular disease.
出处 《中国心血管病研究》 CAS 2007年第11期842-844,共3页 Chinese Journal of Cardiovascular Research
关键词 雷洛昔芬 雌激素类 受体 雌激素 血压 大鼠 Raloxifene Estrogens Receptors, estrogen Blood pressure Rat
  • 相关文献

参考文献9

  • 1[1]Lam PM,Chung TK,Haines C.Where are we with postmenopausal hormone therapy in 2005? Gyencol Endocrinol,2005,21:248-256.
  • 2[2]Bryant HU,Dere WH.Selective estrogen receptor modulators:an alternative to hormone replacement therapy.Proc Soc Exp Bio Med,1998,217:45-52.
  • 3陈小明,吴可贵.雷洛昔芬对心血管的保护作用[J].中国药房,2006,17(17):1346-1348. 被引量:5
  • 4[4]Fuchs YR,Glasebrook AL,Short LL,et al.Raloxifene is a tissueselective agonist/antagonist that functions through the estrogen receptor.Ann NY Acad Sci,1995,761:355-360.
  • 5张廷星,晋学庆,吴可贵,许昌声,陈小明.雌激素对SD大鼠血脂代谢的影响[J].高血压杂志,2005,13(12):797-799. 被引量:8
  • 6[6]Callejo J,Cano A,Medina M,et al.Hormonal environment in the induction of breast cancer in castrated rats using dimethylbenzanthracene:influence of the presence or absence of ovarian activity and of treatment with estradiol,tibolone,and raloxifene.Menopause,2005,12:601-608.
  • 7[7]Barrett-Connor E,Grady D,Sashegi A,et al.Raloxifene and cardiovascular events in osteoporotic postmenopausal women.Fouryear results from the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial.JAMA,2002,287:847-857.
  • 8[8]Mobasseri S,Liebson PR,Klein LW.Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women.Cardiology in Review,2004,12:287-298.
  • 9吴大方,周泉,周岩,刘秦元,丁宝玲.绝经后妇女雌激素水平与血糖及血脂变化的关系[J].中国综合临床,2005,21(1):31-32. 被引量:29

二级参考文献30

  • 1唐细兰,王延东.植物雌激素对心血管系统的保护作用[J].中国药房,2005,16(18):1423-1424. 被引量:1
  • 2张廷星,晋学庆,吴可贵,许昌声,陈小明.雌激素对SD大鼠血脂代谢的影响[J].高血压杂志,2005,13(12):797-799. 被引量:8
  • 3Diamond MP, Grainger D, Diamond MC, et al. Effects of methyltestosterone on insulin secretion and sensitivity in women [ J ]. J Clin Endocrionl Metab,1998,83(12) :4420.
  • 4Ambrus CM,Ambrus JL.Hormone-replacement therapy and coagulation[J].Nengl J Med,1997,17,337:200-201.
  • 5Stomati M,Bernardi F,Luisi S,et al.Conjugated equine estrogens,estrone sulphate and estradiol valerate oral administration in ovariectomized rats:effects on central and peripheral allopregnenolone and β-endorphin[J].Maturitas,2002,20,43:195-206.
  • 6Oakley CM,Overview.Hypertension in postmenopauseal women.270 Madison Avenue[M]//New York,Marcel Dekker,Inc.1996,1-11.
  • 7Lip GY,Zarifis J,Beevers G.Concurrent risk factors.Hypertension in Postmenopauseal Women.270 Madison Avenue[M]//New York.Marcel Dekker,Inc.1996,113-138.
  • 8Ravinkar V,Kramer-Coutinho B.Lipids,hormone replacement therapy,and diet.Hypertension in Postmenopauseal Women.270 Madison Avenue[M]//New York,Marcel Dekker,Inc.1996,149-172.
  • 9Hulley S,Grady D,Bush T,et al.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women[J].JAMA,1998,19,280:605-613.
  • 10Nabulsi AA,Folsom AR,White A,et al.Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women[J].N Engl J Med,1993,328:1069-1075.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部